Cytotoxicity of Liposomal Paclitaxel in Breast Cancer Cell Line MCF-7
- 12 January 2013
- journal article
- research article
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 28 (4) , 358-360
Abstract
Regarding that the breast cancer is the most prevalent disease among women, paclitaxel, an anti-cancer drug, could be used in treatment of this disease. As paclitaxel has adverse effects, it was used of nanoliposome drug delivery technology in order to reduce adverse effects and improve drug efficacy. Certain ratios of phosphatidylcholine, cholesterol and paclitaxel were synthesized to prepare nanoliposomal paclitaxel. Using Zeta sizer device, the mean diameter of nanoliposomal paclitaxel was obtained 421.4 nm and its encapsulation efficiency was 91.3 %. By dialysis, drug release in nanoliposome paclitaxel formulation within 28 h was studied which was 5.53 %. This study showed that cytotoxicity effect of nanoliposomal paclitaxel is more than that of the standard form.Keywords
This publication has 13 references indexed in Scilit:
- Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?Drug Discovery Today, 2012
- Breast-Cancer ScreeningNew England Journal of Medicine, 2011
- Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?Biotechnology Advances, 2011
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast CancerClinical Breast Cancer, 2009
- Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric studyAnnals of Oncology, 2007
- Effect of small-sized liposomal Adriamycin administered by various routes on a metastatic breast cancer modelEndocrine-Related Cancer, 2005
- Recombinant Virus Like Particles as Drug Delivery SystemCurrent Pharmaceutical Biotechnology, 2005
- Developments in liposomal drug delivery systemsExpert Opinion on Biological Therapy, 2001
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Liposomes in immunologyJournal of Biosciences, 1984